Mark Asset Management’s BioNTech BNTX Stock Holding History

Mark Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-22,920	Closed	-$2.47M	–	52
2023 Q2	$2.47M	Hold	22,920	–	–	0.4%	37
2023 Q1	$2.86M	Sell	22,920 -17,194	-43%	-$2.36M	0.52%	40
2022 Q4	$6.03M	Buy	40,114 +15,114	+60%	+$2.33M	1.37%	28
2022 Q3	$3.37M	Sell	25,000 -36,734	-60%	-$5.62M	0.83%	33
2022 Q2	$9.21M	Buy	61,734 +24,265	+65%	+$3.71M	2.22%	17
2022 Q1	$6.39M	Sell	37,469 -52,473	-58%	-$8.82M	0.94%	28
2021 Q4	$23.2M	Buy	89,942 +74,073	+467%	+$20.3M	2.64%	17
2021 Q3	$4.33M	Buy	+15,869	New	+$5.04M	0.47%	41

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Mark Asset Management's BNTX Position: Q3 2023 in Review

Mark Asset Management sold out of BioNTech (BNTX) in Q3 2023, closing a stake of 22,920 shares — an estimated $2.47M sold.

Mark Asset Management first reported a position in BNTX in Q3 2021 and held it in 8 quarters. The position peaked at $23.2M in Q4 2021. 252 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Mark Asset Management reported no remaining BioNTech position as of Q3 2023 after selling out during the quarter.
Mark Asset Management sold 22,920 BioNTech shares in Q3 2023, an estimated $2.47M.
Mark Asset Management first reported a position in BioNTech in Q3 2021 and held it in 8 quarters.
Mark Asset Management's BioNTech position peaked at $23.2M in Q4 2021.
252 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Mark Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.